Skip to main content

Advertisement

Contact Claire Seedhouse

From: Targeting of CD34+CD38-cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia

Contact corresponding author